Research article · 2007
Conference abstractPublished 29 Oct 2012
Design and synthesis of several novel prodrugs via mimicking enzymes catalysis
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Usually, the use of the term prodrug implies a covalent link between a drug and a chemical linker. Generally prodrugs can be defined as pharmacologically inactive chemical derivatives that can be converted in vivo to their parental active drug molecules, enzymatically or none enzymatically, to exert a therapeutic effect. Ideally, the prodrug should be cleaved to the parental drug as soon as the goal is achieved, followed by rapid elimination of the released linker moiety (1-3). The prodrug approach can be useful in the optimization of the clinical application of a drug. The prodrug approach has gained attention as an approach for improving drug therapy in the early1970s. Numerous prodrugs have been designed and synthesized among those the antirheumatic agent oxindole succinate, N-Mannich base of phenylpropanolamine, an imine (Schiff base) prodrug of the anticonvulsant agent progabide, a water soluble prodrugs of the anti-inflammatory drugs valdecoxib, prednisolone and fluocinolone acetonide, a prodrug of the anti-glaucoma epinephrine (dipivefrin) (4). The modern approach to be discussed in this presentation implies design of prodrugs based on intramolecular processes utilizing molecular orbital methods and correlations between experimental and calculated values. No enzyme needed for the catalysis of the conversion of a prodrug to the corresponding drug. The drug release rate is dependent only on the rate limiting step for the reaction by which the prodrug converts to its corresponding prodrug. (5-16).
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 3 May 2019
Design, Synthesis, and characterization of a novel Ciprofloxacin-Antioxidant mutual prodrugs
Conference abstract · 1 Apr 2019
Design, synthesis and biological evaluation of phosphoantigen prodrugs as novel anticancer immunotherapeutics
Research article · 31 Jul 2014
Novel ibuprofen medoxomil prodrug: Design, synthesis and in vitro stability evaluation
Research article · 31 Mar 2014
Design and synthesis of 3-(2-cinnamamidoethylsulfonyl) thiazolidine-4- carboxylate derivatives as novel angiotensin converting enzyme (ACE) inhibitors
More from this journal
The newest in Drug Designing: Open Access.
Research article · 19 Aug 2025
Spectroscopic, Quantum Chemical, Molecular Docking Studies on Cellulose Acetate: Polyvinylidene Fluoride Blend Polymer Membrane for Wound Healing
Research article · 18 Apr 2025
Molecular Docking Studies on Polyphenols of Moringa oleifera for its Enhanced Production of Heamoglobin and Impact of its Extracts on Drosophila melanogaster
Opinion · 4 Mar 2025
Structure-Based Drug Design: Advances in Targeting Oncogenic Kinases
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalDrug Designing: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Rafik Karaman”

